Picture of CNS Pharmaceuticals logo

CNSP CNS Pharmaceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for CNS Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.219-7.39-3.88-9.46-14
Depreciation
Non-Cash Items0.066.590.7471.291.72
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.0470.084-0.4260.834-1.24
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities-0.112-0.716-3.55-7.32-13.5
Capital Expenditures-0.02-0.018-0.006
Purchase of Fixed Assets
Cash from Investing Activities-0.02-0.018-0.006
Financing Cash Flow Items00.470-0.0450
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.2231.1610.314.14.51
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.1110.4456.696.8-9.03

Or unlock with your email

Or unlock with your email